BANCO SANTANDER S.A. (SAN)
Press Release: AAD: new results from Sanofis amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Press Release: AAD: new results from Sanofis amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (92%) **Content type:** Clinical